Mds Podcast

Dr. Schaefer speaks with Dr. Olvera about trending videos of tics and other neurological syndromes on social media.

Dr. Schaefer speaks with Dr. Camargo about the non-motor and prodromal features of dystonia.

Dr. Matarazzo interviews Prof. Fisone about the role of autophagy in Levodopa-Induced Dyskinesia.

Dr. Schaefer discusses with Dr. Garcia Ruiz his recent paper in Movement Disorders Clinical Practice discussing the history and data behind the use of electroconvulsive therapy in Parkinson's disease and other movement disorders.

Dr. Matarazzo interviews Dr. Ray on a recently published article that demonstrates a relationship between changes in cholinergic nuclei in MRI and future gait disorders in Parkinson's disease.

Dr. Matarazzo interviews Dr. De Micco on the functional MRI correlates of anxiety in Parkinson's disease, highlighting the main results of the article she recently published on the topic in the Movement Disorders Journal.

Dr. Schaefer speaks with Dr. Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions.

Dr. Wu discusses a newly-described peripherally-induced movement disorder (PIMD), and discusses with Dr. Schaefer the potential pathophysiologies of PIMDs.

Dr. Matarazzo interviews Dr. Standaert about the review article he recently published on neuroinflammation in Parkinson's disease, including the main evidence of its role on the pathogenesis of the disease and how understanding it better may help us discovering new therapeutic targets.

Dr. Brit Mollenhauer discusses the recent advances in the use of neurofilament light chain for the diagnosis and follow up of Parkinson's disease and related disorders, highlighting the results of a recent longitudinal study.

Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort. Read the article

In this interview, Prof. Brit Mollenhauer provides insight into how researchers have been coping with the COVID-19 pandemic. Read the article

Dr. Michele Matarazzo interviews Dr. Kazuto Tsukita, the first author of the article awarded as "2020 Review Article from Movement Disorders" on the advances of in-vivo alpha-synuclein detection as a biomarker for Parkinson. Read the article

Dr. Michele Matarazzo interviews Dr. Amy Amara, the first author of the article awarded as "2020 Research Article from Movement Disorders" on the effects of exercise on sleep in Parkinson's disease. Read the article

In this interview, Prof. Deuschl highlights the main results of the EARLYSTIM project, focusing on non-motor outcomes, and especially on the effects of DBS on Social and Occupational Functioning in Parkinson's Disease.

Preprint articles of scientific results have been thrust into the spotlight due to the desire for rapid results pertaining to COVID-19. Here, we dive into the trend with Movement Disorders’ editor, Dr. Jon Stoessl. Read the article

Dr. Matarazzo interviews Dr. Anette Schrag about the recently published article on late-stage parkinsonism and related neuropsychiatric complications. Why is it important? And are we doing enough to help patients at this stage? Read the article

Dr. Matarazzo interviews Prof. Roy Alcalay on the effects that the COVID-19 pandemic is having on the clinical activity and how it is changing the way we see patients. Will telemedicine be an integrating part of our clinical practice?

In this interview the president of the MDS, Prof. Claudia Trenkwalder shares the main changes and strategies that the MDS is implementing to adapt to the COVID-19 pandemic, including the replacement of the International MDS congress with a virtual meeting.

Dr. Matarazzo interviews Prof. Angelo Antonini on the effect of the COVID-19 pandemic on Parkinson's disease and other movement disorders patients and how to manage them. And also, what is the evidence of a link between COVID-19 and Parkinson's disease? Read the article